ATE96313T1 - Fettsaeure-zusammensetzungen. - Google Patents
Fettsaeure-zusammensetzungen.Info
- Publication number
- ATE96313T1 ATE96313T1 AT84304610T AT84304610T ATE96313T1 AT E96313 T1 ATE96313 T1 AT E96313T1 AT 84304610 T AT84304610 T AT 84304610T AT 84304610 T AT84304610 T AT 84304610T AT E96313 T1 ATE96313 T1 AT E96313T1
- Authority
- AT
- Austria
- Prior art keywords
- fatty acid
- acid compositions
- efa
- gamma
- linolenic acid
- Prior art date
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title 1
- 229930195729 fatty acid Natural products 0.000 title 1
- 239000000194 fatty acid Substances 0.000 title 1
- 150000004665 fatty acids Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- TWSWSIQAPQLDBP-CGRWFSSPSA-N (7e,10e,13e,16e)-docosa-7,10,13,16-tetraenoic acid Chemical compound CCCCC\C=C\C\C=C\C\C=C\C\C=C\CCCCCC(O)=O TWSWSIQAPQLDBP-CGRWFSSPSA-N 0.000 abstract 1
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 abstract 1
- 235000021292 Docosatetraenoic acid Nutrition 0.000 abstract 1
- TWSWSIQAPQLDBP-UHFFFAOYSA-N adrenic acid Natural products CCCCCC=CCC=CCC=CCC=CCCCCCC(O)=O TWSWSIQAPQLDBP-UHFFFAOYSA-N 0.000 abstract 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 1
- 229960002733 gamolenic acid Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838319073A GB8319073D0 (en) | 1983-07-14 | 1983-07-14 | Fatty acid compositions |
| EP84304610A EP0132089B1 (de) | 1983-07-14 | 1984-07-05 | Fettsäure-Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE96313T1 true ATE96313T1 (de) | 1993-11-15 |
Family
ID=10545711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT84304610T ATE96313T1 (de) | 1983-07-14 | 1984-07-05 | Fettsaeure-zusammensetzungen. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0132089B1 (de) |
| JP (1) | JPS6038324A (de) |
| AT (1) | ATE96313T1 (de) |
| AU (1) | AU562938B2 (de) |
| CA (1) | CA1251736A (de) |
| DE (1) | DE3486235T2 (de) |
| GB (1) | GB8319073D0 (de) |
| HK (1) | HK37694A (de) |
| IE (1) | IE61082B1 (de) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1239587A (en) * | 1983-10-24 | 1988-07-26 | David Rubin | Combined fatty acid composition for lowering blood cholestrol and triglyceride levels |
| GB8507058D0 (en) * | 1985-03-19 | 1985-04-24 | Efamol Ltd | Pharmaceutical & dietary compositions |
| GB8516906D0 (en) * | 1985-07-04 | 1985-08-07 | Efamol Ltd | Pharmaceutical & dietary composition |
| GB8524276D0 (en) * | 1985-10-02 | 1985-11-06 | Efamol Ltd | Pharmaceutical & dietary compositions |
| SE8505569D0 (sv) * | 1985-11-25 | 1985-11-25 | Aco Laekemedel Ab | Enteralt preparat |
| GB8601915D0 (en) * | 1986-01-27 | 1986-03-05 | Efamol Ltd | Pharmaceutical compositions |
| IT1223290B (it) | 1987-07-27 | 1990-09-19 | Indena Spa | Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche |
| US5034415A (en) * | 1987-08-07 | 1991-07-23 | Century Laboratories, Inc. | Treatment of diabetes mellitus |
| GB8918294D0 (en) * | 1989-08-10 | 1989-09-20 | Efamol Holdings | Pharmaceutical compositions |
| US5922345A (en) * | 1990-12-07 | 1999-07-13 | Scotia Holdings Plc | Nutrition |
| GB9026648D0 (en) * | 1990-12-07 | 1991-01-23 | Efamol Holdings | Nutrition |
| GB9304746D0 (en) * | 1993-03-09 | 1993-04-28 | Scotia Holdings Plc | Treatment of viral infections |
| US5696166A (en) * | 1995-10-31 | 1997-12-09 | Yanni; John M. | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| US5866150A (en) * | 1996-03-20 | 1999-02-02 | Aquaculture Technology Incorporated | Antibacterially active extracts from the marine algae chaetoceros and methods of use |
| GB9901808D0 (en) * | 1999-01-27 | 1999-03-17 | Scarista Limited | Drugs for treatment of psychiatric and brain disorders |
| TWI225398B (en) * | 1999-07-14 | 2004-12-21 | R Tech Ueno Ltd | Composition for treatment of external secretion disorders |
| JP2003513910A (ja) | 1999-11-09 | 2003-04-15 | アルコン，インコーポレイテッド | １５−ヒドロキシエイコサテトラエン酸のヘテロ原子分断類似体および使用方法 |
| US6353032B1 (en) | 1999-11-09 | 2002-03-05 | Alcon Universal Ltd. | Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use |
| US6552084B2 (en) | 1999-11-09 | 2003-04-22 | Alcon Universal Ltd. | Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| HK1045985B (en) | 1999-11-09 | 2004-04-23 | Alcon, Inc. | 15-hydroxyeicosatetraenoic acid-related compounds and methods of use |
| US6458854B2 (en) | 1999-11-09 | 2002-10-01 | Alcon Universal Ltd. | Phospholipids of hydroxyeicosatetraenoic acid-like derivatives and methods of use |
| US6320062B1 (en) | 1999-11-09 | 2001-11-20 | Alcon Universal Ltd. | 15-hydroxyeicosatetraenoic acid analogs with enhanced metabolic stability and methods of their use in treating dry eye disorders |
| CA2386619A1 (en) | 1999-11-09 | 2001-05-17 | Alcon, Inc. | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| US6803385B2 (en) | 1999-11-09 | 2004-10-12 | Alcon, Inc. | Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| AU776153B2 (en) | 1999-11-09 | 2004-08-26 | Alcon Inc. | Benzenoid derivatives of 15-hydroxyeicosatetraenoic acid and methods of their use in treating dry eye disorders |
| WO2001034553A2 (en) | 1999-11-09 | 2001-05-17 | Alcon Universal Ltd. | 2,2-difluoro 15-hydroxyeicosatetraenoic acid analogs and methods of use |
| DE60007548T2 (de) | 1999-11-09 | 2004-06-17 | Alcon, Inc. | Omega kettenmodifizierte hydroxyeicosatetraensäure derivate verwendbar in der behandlung der "trockenes auge" krankheit |
| DK1228028T3 (da) | 1999-11-09 | 2005-11-14 | Alcon Inc | Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser |
| PT1228027E (pt) | 1999-11-09 | 2004-08-31 | Alcon Inc | Derivados de 15-hete com heteroatomo substituinte em posicao 3 e homologos com dois carbonos e metodos de utilizacao |
| RS51031B (sr) * | 2001-04-30 | 2010-10-31 | Trommsdorff Gmbh & Co.Kg.Arzneimittel | Farmaceutski aktivni estri uridina |
| EP1583527A1 (de) | 2002-06-14 | 2005-10-12 | Alcon, Inc. | Verwendung von hydroxyeicosatetraensäure verbindungen zur behandlung augenentzendungen |
| US20040044079A1 (en) * | 2002-09-04 | 2004-03-04 | The Iams Company | Methods and compositions for weight control |
| GB0907413D0 (en) | 2009-04-29 | 2009-06-10 | Equateq Ltd | Novel methods |
| US8293790B2 (en) | 2011-10-19 | 2012-10-23 | Dignity Sciences Limited | Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof |
| EP3151825B1 (de) | 2014-06-04 | 2020-03-25 | DS Biopharma Limited | Pharmazeutische zusammensetzungen enthaltend dgla und verwendung derselben |
| US20210315851A1 (en) | 2020-04-03 | 2021-10-14 | Afimmune Limited | Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1082624A (en) * | 1965-02-26 | 1967-09-06 | Calmic Ltd | Improvements in or relating to therapeutically active compounds |
| GB1476624A (en) * | 1973-05-30 | 1977-06-16 | Cepbepe | Tranquiliser medicaments |
| GB1580444A (en) * | 1976-11-04 | 1980-12-03 | Bio Oil Res | Pharmaceutical compositions |
| GB2033745B (en) * | 1978-05-26 | 1983-08-17 | Wellcome Found | Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions |
| GB2098065A (en) * | 1981-04-14 | 1982-11-17 | Nippon Suisan Kaisha Ltd | Antithrombotic compositions containing docosahexaenoic acid |
| GB8302708D0 (en) * | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
-
1983
- 1983-07-14 GB GB838319073A patent/GB8319073D0/en active Pending
-
1984
- 1984-07-05 EP EP84304610A patent/EP0132089B1/de not_active Expired - Lifetime
- 1984-07-05 AT AT84304610T patent/ATE96313T1/de not_active IP Right Cessation
- 1984-07-05 DE DE84304610T patent/DE3486235T2/de not_active Expired - Fee Related
- 1984-07-06 IE IE173884A patent/IE61082B1/en not_active IP Right Cessation
- 1984-07-09 CA CA000458469A patent/CA1251736A/en not_active Expired
- 1984-07-13 AU AU30577/84A patent/AU562938B2/en not_active Ceased
- 1984-07-13 JP JP59144532A patent/JPS6038324A/ja active Pending
-
1994
- 1994-04-21 HK HK37694A patent/HK37694A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1251736A (en) | 1989-03-28 |
| EP0132089B1 (de) | 1993-10-27 |
| IE841738L (en) | 1985-01-14 |
| HK37694A (en) | 1994-04-29 |
| AU3057784A (en) | 1985-01-17 |
| JPS6038324A (ja) | 1985-02-27 |
| DE3486235T2 (de) | 1994-04-14 |
| AU562938B2 (en) | 1987-06-25 |
| GB8319073D0 (en) | 1983-08-17 |
| DE3486235D1 (de) | 1993-12-02 |
| EP0132089A1 (de) | 1985-01-23 |
| IE61082B1 (en) | 1994-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3486235D1 (de) | Fettsäure-Zusammensetzungen. | |
| NO932983L (no) | Fettsyrebehandling | |
| FI893805A0 (fi) | Fettsyrakomposition. | |
| EP0303915A3 (en) | Retinoids for the treatment of skin damaged by light | |
| ES2107622T3 (es) | Medicamento para el tratamiento de la distrofia vulvar o la sequedad vaginal. | |
| DE3875286D1 (de) | Essentielle fettsaeure enthaltende zusammensetzungen. | |
| ATE32430T1 (de) | Pharmazeutische zusammensetzungen. | |
| ATE107515T1 (de) | Zusammensetzung zur behandlung von entzündung. | |
| ATE22532T1 (de) | Pharmazeutische zusammensetzung. | |
| ATE22804T1 (de) | Pharmazeutische zusammensetzung. | |
| OA08843A (fr) | Nouvelle composition ophtalmologique. | |
| ATE19855T1 (de) | Pharmazeutische und diaetetische zusammensetzung. | |
| ATE63684T1 (de) | Deodorant. | |
| ATE87476T1 (de) | Fluessige orale formulierung. | |
| JPS5251755A (en) | Agents for treating excreta | |
| NO874241D0 (no) | Terapeutisk aktive salter. | |
| IT8323601A0 (it) | Impiego di ibuprofene e flurbiprofene nella cura dell'erpete. | |
| FR2336945A1 (fr) | Composition pour la sterilisation des femmes et des femelles d'animaux | |
| MX9203508A (es) | 1,7-difenil-3-metilaza -7-ciano-8-metilnonano para usarse en el tratamiento de enfermedades. | |
| IT7807214A0 (it) | Impianto alloplastico per la ritenzione delle protesi mobili senza palato e dell'inferiore senza creste alveolari. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |